MAX HEALTHCARE INS LTD Fair Value
MAXHEALTH · Healthcare · Current price ₹1,003
| Method | Fair value | Status |
|---|---|---|
| Residual income | ₹115 | 15% ROE fading to 12% over ~3 yrs, on ₹110 book |
| Relative P/E | ₹959 | EPS × 64.7 peer-median P/E |
| Graham floor | ₹192 | Conservative floor: √(22.5 × EPS × book value/share) |
| Analyst target | ₹1,181 | Street consensus 12-month target price |
Is MAX HEALTHCARE INS LTD undervalued?
DocStoX estimates the fair value of MAX HEALTHCARE INS LTD at ₹511 per share, versus the current market price of ₹1,003. That puts the stock about -49.1% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 4 independent methods: Residual income (₹115), Relative P/E (₹959), Graham floor (₹192), Analyst target (₹1,181). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹115 (bear) to ₹511 (base) to ₹1,181 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
More on MAX HEALTHCARE INS LTD
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.